Four major professional allergy organizations have launched a new effort to raise worldwide awareness of allergic diseases.
The International Collaboration on Asthma, Allergy, and Immunology (iCAALL) is a project of the American Academy of Allergy, Asthma & Immunology (AAAAI), the American College of Allergy, Asthma & Immunology (ACAAI), the European Academy of Allergy and Clinical Immunology (EAACI), and the World Allergy Organization (WAO). The leaders of each group announced the new initiative at a press briefing held during the AAAAI’s annual meeting in Orlando. An editorial introducing the initiative is online and will be published in the April issue of the Journalof Allergy and Clinical Immunology.
“The world has experienced a tremendous increase in the prevalence of allergic diseases and asthma over the last 50 years,” EAACI president Dr. Cezmi Akdis said, noting that asthma currently affects 8%-12% of the developed world, and allergic rhinitis, approximately 20%-25%. Asthma care costs more than 20 billion Euros today and is expected to jump to 200 billion Euros in 2050. Yet, current research funding is only about 2%-3% of that devoted to diseases such as cancer and HIV/AIDS.
“We need better treatments and tailored care. We need more and more research … I am confident that iCAALL will result in a greater awareness about allergies, asthma, and immunologic diseases all around the world, resulting in prevention, cure, and better patient care, which is only possible by increased allocation of resources for research,” Dr. Akdis said.
According to WAO president Dr. Ruby Pawankar, “Allergies and asthma are no longer diseases of just the developed world … It’s a huge problem in the industrializing and the developing world.” She pointed out that allergic disease has been absent from the recent World Health Organization/United Nations focus on noncommunicable diseases (NCDs), highlighted by a high-level meeting last September.
“The WHO and UN have made efforts toward giving more attention to NCDs. However, the area of allergy and asthma and clinical immunologic diseases needs to get to the stage to be represented at the WHO and UN.” To that end, WAO has issued a White Book on allergic disease with reports from 62 member countries, Dr. Pawankar said.
Dr. Wesley Burks described the iCAALL centerpiece initiative, a series of International Consensus (ICON) reports. The first ICON, on food allergy, is already online. It includes breastfeeding in the first 4-6 months as a key recommendation for reducing the risk for allergic disease. Food allergy is rising worldwide; in China, for example, food allergy has almost doubled from 3.9% 10 years ago to 7.7% today. “In a country thought not to have a lot of food allergy, that’s a significant change,” said Dr. Burks, president-elect of AAAAI.
Dr. Stanley Fineman, ACAAI president, outlined the plans for dissemination of upcoming ICONs: One on pediatric asthma is to be released at the EAACI Congress in June in Geneva; the next, on angioedema, at the ACAAI meeting in November in Anaheim, Calif.; and then one on eosinophilic disorders at the WAO’s International Scientific Conference in December in Hyderabad, India.
Dr. Dennis K. Ledford, outgoing AAAAI president and iCAALL chair, said that other initiatives will incorporate additional means for disseminating research and increasing support for research. “It’s an evolving collaborative, happening as we speak.”
-Miriam E. Tucker (@MiriamETucker on Twitter)